| 86R3759 MM-D  
---|---  
|  By: Davis of Harris | H.B. No. 3485  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to the billing codes used for the administration of tissue  
| plasminogen activator by ambulance providers under the Medicaid and  
| Medicare programs.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Subchapter B, Chapter 531, Government Code, is  
| amended by adding Section 531.024136 to read as follows:  
|  _Sec._ ___531.024136._ _____MEDICAID BILLING CODE FOR TISSUE_  
| _PLASMINOGEN ACTIVATOR ADMINISTERED BY AMBULANCE PROVIDERS. The_  
| _executive commissioner by rule shall adopt a specific procedure or_  
| _other billing code under Medicaid for the administration of tissue_  
| _plasminogen activator by an ambulance provider._  
|  SECTION 2. As soon as possible after the effective date of  
| this Act, the Health and Human Services Commission shall request  
| that the Centers for Medicare and Medicaid Services or other  
| appropriate federal agency adopt a specific procedure or other  
| billing code for the administration of tissue plasminogen activator  
| by an ambulance provider under the Medicare program.  
|  SECTION 3. If before implementing any provision of this Act  
| a state agency determines that a waiver or authorization from a  
| federal agency is necessary for implementation of that provision,  
| the agency affected by the provision shall request the waiver or  
| authorization and may delay implementing that provision until the  
| waiver or authorization is granted.  
|  SECTION 4. This Act takes effect September 1, 2019.

